Which cytologically proven node-positive breast cancer patients can avoid axillary lymph dissection after neaodjuvant chemotherapy?

dc.contributor.author	Eralp, Y.
dc.contributor.author	Fayda, M.
dc.contributor.author	Saip, P.
dc.contributor.author	Kurul, S.
dc.contributor.author	Aydiner, A.
dc.contributor.author	Karanlik, H.
dc.contributor.author	Ilhan, B.
dc.contributor.author	Yavuz, E.
dc.contributor.author	Mudun, A.
dc.date.accessioned	2021-03-02T20:37:22Z
dc.date.available	2021-03-02T20:37:22Z
dc.identifier.citation	Karanlik H., Ilhan B., Fayda M., Yavuz E., Mudun A., Saip P., Eralp Y., Kurul S., Aydiner A., "Which cytologically proven node-positive breast cancer patients can avoid axillary lymph dissection after neaodjuvant chemotherapy?", CANCER RESEARCH, cilt.73, 2013
dc.identifier.issn	0008-5472
dc.identifier.other	vv_1032021
dc.identifier.other	av_02e4094d-7240-4dc8-be7f-cb7e2ddf90be
dc.identifier.uri	http://hdl.handle.net/20.500.12627/7889
dc.identifier.uri	https://doi.org/10.1158/0008-5472.sabcs13-p1-01-22
dc.language.iso	eng
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Klinik Tıp
dc.subject	ONKOLOJİ
dc.title	Which cytologically proven node-positive breast cancer patients can avoid axillary lymph dissection after neaodjuvant chemotherapy?
dc.type	Makale
dc.relation.journal	CANCER RESEARCH
dc.contributor.department	, ,
dc.identifier.volume	73
dc.contributor.firstauthorID	211932

Files in this item

Files	Size	Format	View
There are no files associated with this item.